US hospitals turn down remdesivir, limit use to sickest COVID-19 patients

Some hospitals said they are still buying the Gilead Sciences medicine to build inventory in case the pandemic accelerates over the winter. But they said current supplies are adequate, in part because they are limiting use to severely ill patients.

from Moneycontrol Latest News https://ift.tt/3hmmjeX